Table 4.
Variable | Category | N | 1-yr PFS (%) | 95% CI | P |
---|---|---|---|---|---|
Sex | F | 30 | 65 | 49–87 | 0.056 |
M | 41 | 39 | 26–60 | ||
Age | <=60 | 42 | 49 | 35–69 | 0.77 |
>60 | 29 | 51 | 34–76 | ||
Extrahepatic Disease | No | 47 | 54 | 41–73 | 0.26 |
Yes | 24 | 42 | 26–70 | ||
CRS | 0–2 | 47 | 62 | 48–79 | <0.01 |
3–4 | 24 | 26 | 13–54 | ||
Electrode | 1 | 14 | 61 | 39–95 | 0.15 |
2 | 30 | 37 | 22–63 | ||
3 | 27 | 57 | 40–82 | ||
Prior HAIC | No | 41 | 48 | 34–68 | 0.18 |
Yes | 30 | 53 | 36–77 | ||
* Nodal Status of Primary | Negative | 16 | 83 | 65–100 | 0.01 |
Positive | 55 | 47 | 31–65 | ||
* Number of Tumors | Solitary | 53 | 61 | 47–79 | <0.01 |
Multiple | 18 | 37 | 17–78 | ||
* DFI | >12m | 20 | 62 | 40–95 | 0.15 |
<12m | 51 | 52 | 38–72 | ||
* Size | ≤3cm | 64 | 54 | 34–64 | 0.02 |
>3cm | 7 | 17 | 3–100 |
factor included in CRS; CRS= clinical risk score